DLK1 and Parkinson disease: We evaluated the recent literature on candidate blood biomarkers in Parkinson’s disease patients and observed five differentially methylated genes (COL9A2, SCNN1A, AMICA1, SLC16A3, and DLK1) in these studies within our conserved human regions [29, 75].